Literature DB >> 6298269

Autonomic nervous system abnormalities in cystic fibrosis.

P B Davis, M Kaliner.   

Abstract

The basic defect in cystic fibrosis, the most common lethal genetic diseases of white Americans, is unknown, but the character of the generalized exocrinopathy suggests some disorder of the regulation and control of the process of glandular secretion. Definite abnormalities in all branches of the autonomic nervous system have been demonstrated in patients with cystic fibrosis, including increased sensitivity to alpha-adrenergically stimulated pupillary dilation; increased responsiveness to cholinergic stimulation of pupillary constriction, parotid saliva secretion, and eccrine sweat secretion; and decreased responsiveness to beta-adrenergic stimulation of the cardiovascular system as well as circulating lymphocytes and granulocytes. Since these abnormalities also occur in asymptomatic heterozygotes for cystic fibrosis (parents of patients), they are likely to be inherited characteristics and not secondarily acquired. This constellation of inherited autonomic abnormalities--alpha-adrenergic and cholinergic hyperresponsiveness and beta-adrenergic resistance--may contribute to the pathophysiology of cystic fibrosis and may also be an important clue to the nature of the basic defect.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298269     DOI: 10.1016/0021-9681(83)90062-0

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  9 in total

Review 1.  Autonomic dysfunction in cystic fibrosis.

Authors:  A Mirakhur; M J Walshaw
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  [Recommendations for implementing bronchial provocation tests with pharmacologic substances. German Society of Pneumology--Scientific "Bronchial Provocation Tests" Study Group].

Authors:  G Klein
Journal:  Med Klin (Munich)       Date:  1997-08-15

3.  Effects of exercise intensity compared to albuterol in individuals with cystic fibrosis.

Authors:  Courtney M Wheatley; Sarah E Baker; Mary A Morgan; Marina G Martinez; Wayne J Morgan; Eric C Wong; Stephen R Karpen; Eric M Snyder
Journal:  Respir Med       Date:  2014-12-18       Impact factor: 3.415

Review 4.  Cystic Fibrosis and the Nervous System.

Authors:  Leah R Reznikov
Journal:  Chest       Date:  2016-11-19       Impact factor: 9.410

5.  CFTR-deficient pigs display peripheral nervous system defects at birth.

Authors:  Leah R Reznikov; Qian Dong; Jeng-Haur Chen; Thomas O Moninger; Jung Min Park; Yuzhou Zhang; Jianyang Du; Michael S Hildebrand; Richard J H Smith; Christoph O Randak; David A Stoltz; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

6.  Exclusion of catalytic and regulatory subunits of cAMP-dependent protein kinase as candidate genes for the defect causing cystic fibrosis.

Authors:  P Scambler; O Oyen; B Wainwright; M Farrall; H Y Law; X Estivill; M Sandberg; R Williamson; T Jahnsen
Journal:  Am J Hum Genet       Date:  1987-11       Impact factor: 11.025

7.  Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis.

Authors:  Melitta A McNarry; Kelly A Mackintosh
Journal:  PLoS One       Date:  2016-03-11       Impact factor: 3.240

8.  Regional brain tissue changes in patients with cystic fibrosis.

Authors:  Bhaswati Roy; Marlyn S Woo; Susana Vacas; Patricia Eshaghian; Adupa P Rao; Rajesh Kumar
Journal:  J Transl Med       Date:  2021-10-09       Impact factor: 5.531

Review 9.  Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.

Authors:  Kalina R Atanasova; Leah R Reznikov
Journal:  Respir Res       Date:  2018-08-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.